ENV-308

all catalysts(0)

nothing on the calendar yet

News(2)

• Enveda’s exercise-simulating obesity tablet clears early clinical test
  Touting an “exceptional” gastrointestinal safety profile for its oral obesity drug candidate in a study of healthy volunteers, Enveda plans to test the asset in people stopping GLP-1 treatment.
  biospace · 2d ago
• STAT+: A pill that mimics exercise? Early results on drug designed to maintain both weight loss and muscle mass
  Colorado biotech Enveda reports preliminary results on a drug to help people maintain weight loss after GLP-1 use. Just don't call it exercise in a pill.
  stat · 3d ago